Profile
Corporate information
Affiliate of
Registration country
Affiliate of
Registration country
Investment activity status
Active investor
Company type
The corporate venture fund initiative of Canterbury Scientific Ltd.Overview
CS Ventures is the corporate venture fund initiative of Canterbury Scientific Ltd., a leading OEM developer and supplier of high quality in vitro diagnostic controls and calibrators for diabetic and haemoglobinopathy applications worldwide. CS Ventures was established in 2019 to invest in promising IVD opportunities that align with Canterbury Scientific’s existing capabilities and to diversify into applications beyond diabetes mellitus.
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Vivodyne Inc Philadelphia-based biotech that tests its drug candidates on lab-grown human organs. |
United States | 22 Nov 2023 | Seed Initial investment. Round participant. Active |